Effects of ω-3 Fatty Acids and Catechins on Fatty Acid Synthase in the Prostate: A Randomized Controlled Trial

Zhenzhen Zhang, Mark Garzotto, Tomasz (Tom) Beer, Philippe Thuillier, Stephen Lieberman, Motomi (Tomi) Mori, Wesley A. Stoller, Paige E. Farris, Jackilen (Jackie) Shannon

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Animal and human studies suggest fish oil and green tea may have protective effect on prostate cancer. Fatty acid synthase (FAS) has been hypothesized to be linked to chemoprotective effects of both compounds. This study evaluated the independent and joint effects of fish oil (FO) and green tea supplement (epigallocatechin-3-gallate, EGCG) on FAS and Ki-67 levels in prostate tissue. Through a double-blinded, randomized controlled trial with 2 × 2 factorial design, 89 men scheduled for repeat prostate biopsy following an initial negative prostate biopsy were randomized into either FO alone (1.9 g DHA + EPA/day), EGCG alone (600 mg/day), a combination of FO and EGCG, or placebo. We used linear mixed-effects models to test the differences of prostate tissue FAS and Ki-67 by immunohistochemistry between pre- and post-intervention within each group, as well as between treatment groups. Results did not show significant difference among treatment groups in pre-to-post-intervention changes of FAS (P = 0.69) or Ki-67 (P = 0.26). Comparing placebo group with any of the treatment groups, we did not find significant difference in FAS or Ki-67 changes (all P > 0.05). Results indicate FO or EGCG supplementation for a short duration may not be sufficient to produce biologically meaningful changes in FAS or Ki-67 levels in prostate tissue.

Original languageEnglish (US)
Pages (from-to)1309-1319
Number of pages11
JournalNutrition and Cancer
Volume68
Issue number8
DOIs
StatePublished - Nov 16 2016

Fingerprint

Fatty Acid Synthases
Catechin
Fish Oils
Prostate
Fatty Acids
Randomized Controlled Trials
Tea
Placebos
Biopsy
Prostatic Neoplasms
Therapeutics
Immunohistochemistry
epigallocatechin gallate

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Oncology
  • Nutrition and Dietetics
  • Cancer Research

Cite this

Effects of ω-3 Fatty Acids and Catechins on Fatty Acid Synthase in the Prostate : A Randomized Controlled Trial. / Zhang, Zhenzhen; Garzotto, Mark; Beer, Tomasz (Tom); Thuillier, Philippe; Lieberman, Stephen; Mori, Motomi (Tomi); Stoller, Wesley A.; Farris, Paige E.; Shannon, Jackilen (Jackie).

In: Nutrition and Cancer, Vol. 68, No. 8, 16.11.2016, p. 1309-1319.

Research output: Contribution to journalArticle

Zhang, Zhenzhen ; Garzotto, Mark ; Beer, Tomasz (Tom) ; Thuillier, Philippe ; Lieberman, Stephen ; Mori, Motomi (Tomi) ; Stoller, Wesley A. ; Farris, Paige E. ; Shannon, Jackilen (Jackie). / Effects of ω-3 Fatty Acids and Catechins on Fatty Acid Synthase in the Prostate : A Randomized Controlled Trial. In: Nutrition and Cancer. 2016 ; Vol. 68, No. 8. pp. 1309-1319.
@article{b64c7091f66249bf84439ad9042930b3,
title = "Effects of ω-3 Fatty Acids and Catechins on Fatty Acid Synthase in the Prostate: A Randomized Controlled Trial",
abstract = "Animal and human studies suggest fish oil and green tea may have protective effect on prostate cancer. Fatty acid synthase (FAS) has been hypothesized to be linked to chemoprotective effects of both compounds. This study evaluated the independent and joint effects of fish oil (FO) and green tea supplement (epigallocatechin-3-gallate, EGCG) on FAS and Ki-67 levels in prostate tissue. Through a double-blinded, randomized controlled trial with 2 × 2 factorial design, 89 men scheduled for repeat prostate biopsy following an initial negative prostate biopsy were randomized into either FO alone (1.9 g DHA + EPA/day), EGCG alone (600 mg/day), a combination of FO and EGCG, or placebo. We used linear mixed-effects models to test the differences of prostate tissue FAS and Ki-67 by immunohistochemistry between pre- and post-intervention within each group, as well as between treatment groups. Results did not show significant difference among treatment groups in pre-to-post-intervention changes of FAS (P = 0.69) or Ki-67 (P = 0.26). Comparing placebo group with any of the treatment groups, we did not find significant difference in FAS or Ki-67 changes (all P > 0.05). Results indicate FO or EGCG supplementation for a short duration may not be sufficient to produce biologically meaningful changes in FAS or Ki-67 levels in prostate tissue.",
author = "Zhenzhen Zhang and Mark Garzotto and Beer, {Tomasz (Tom)} and Philippe Thuillier and Stephen Lieberman and Mori, {Motomi (Tomi)} and Stoller, {Wesley A.} and Farris, {Paige E.} and Shannon, {Jackilen (Jackie)}",
year = "2016",
month = "11",
day = "16",
doi = "10.1080/01635581.2016.1224365",
language = "English (US)",
volume = "68",
pages = "1309--1319",
journal = "Nutrition and Cancer",
issn = "0163-5581",
publisher = "Routledge",
number = "8",

}

TY - JOUR

T1 - Effects of ω-3 Fatty Acids and Catechins on Fatty Acid Synthase in the Prostate

T2 - A Randomized Controlled Trial

AU - Zhang, Zhenzhen

AU - Garzotto, Mark

AU - Beer, Tomasz (Tom)

AU - Thuillier, Philippe

AU - Lieberman, Stephen

AU - Mori, Motomi (Tomi)

AU - Stoller, Wesley A.

AU - Farris, Paige E.

AU - Shannon, Jackilen (Jackie)

PY - 2016/11/16

Y1 - 2016/11/16

N2 - Animal and human studies suggest fish oil and green tea may have protective effect on prostate cancer. Fatty acid synthase (FAS) has been hypothesized to be linked to chemoprotective effects of both compounds. This study evaluated the independent and joint effects of fish oil (FO) and green tea supplement (epigallocatechin-3-gallate, EGCG) on FAS and Ki-67 levels in prostate tissue. Through a double-blinded, randomized controlled trial with 2 × 2 factorial design, 89 men scheduled for repeat prostate biopsy following an initial negative prostate biopsy were randomized into either FO alone (1.9 g DHA + EPA/day), EGCG alone (600 mg/day), a combination of FO and EGCG, or placebo. We used linear mixed-effects models to test the differences of prostate tissue FAS and Ki-67 by immunohistochemistry between pre- and post-intervention within each group, as well as between treatment groups. Results did not show significant difference among treatment groups in pre-to-post-intervention changes of FAS (P = 0.69) or Ki-67 (P = 0.26). Comparing placebo group with any of the treatment groups, we did not find significant difference in FAS or Ki-67 changes (all P > 0.05). Results indicate FO or EGCG supplementation for a short duration may not be sufficient to produce biologically meaningful changes in FAS or Ki-67 levels in prostate tissue.

AB - Animal and human studies suggest fish oil and green tea may have protective effect on prostate cancer. Fatty acid synthase (FAS) has been hypothesized to be linked to chemoprotective effects of both compounds. This study evaluated the independent and joint effects of fish oil (FO) and green tea supplement (epigallocatechin-3-gallate, EGCG) on FAS and Ki-67 levels in prostate tissue. Through a double-blinded, randomized controlled trial with 2 × 2 factorial design, 89 men scheduled for repeat prostate biopsy following an initial negative prostate biopsy were randomized into either FO alone (1.9 g DHA + EPA/day), EGCG alone (600 mg/day), a combination of FO and EGCG, or placebo. We used linear mixed-effects models to test the differences of prostate tissue FAS and Ki-67 by immunohistochemistry between pre- and post-intervention within each group, as well as between treatment groups. Results did not show significant difference among treatment groups in pre-to-post-intervention changes of FAS (P = 0.69) or Ki-67 (P = 0.26). Comparing placebo group with any of the treatment groups, we did not find significant difference in FAS or Ki-67 changes (all P > 0.05). Results indicate FO or EGCG supplementation for a short duration may not be sufficient to produce biologically meaningful changes in FAS or Ki-67 levels in prostate tissue.

UR - http://www.scopus.com/inward/record.url?scp=84988409410&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988409410&partnerID=8YFLogxK

U2 - 10.1080/01635581.2016.1224365

DO - 10.1080/01635581.2016.1224365

M3 - Article

C2 - 27646578

AN - SCOPUS:84988409410

VL - 68

SP - 1309

EP - 1319

JO - Nutrition and Cancer

JF - Nutrition and Cancer

SN - 0163-5581

IS - 8

ER -